(BKTI) BK Technologies - Overview
Stock: Two-Way Radios, P25 Digital, Analog Radios, Push-To-Talk, SaaS
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 62.4% |
| Relative Tail Risk | -11.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.37 |
| Alpha | 108.54 |
| Character TTM | |
|---|---|
| Beta | 1.203 |
| Beta Downside | 1.569 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.89% |
| CAGR/Max DD | 1.15 |
Description: BKTI BK Technologies January 01, 2026
BK Technologies Corp. (BKTI) designs, manufactures, and markets two-way land-mobile radios (LMR) for handheld and vehicle-mounted use, primarily serving U.S. and international government, public-safety, military, and commercial customers. Its product lines include the KNG and BKR series, which support both P25 digital and analog waveforms, as well as a niche portfolio of intellectual-property-focused radio solutions. The company also operates InteropONE, a push-to-talk-over-cellular (PTTOC) SaaS platform that lets incident commanders create ad-hoc voice groups directly from smartphones.
Key market indicators suggest modest upside potential: the U.S. public-safety communications market is projected to grow at ~4% CAGR through 2028, driven by federal funding for P25 migration and expanding LTE-based mission-critical services. BKTI reported FY2023 revenue of roughly $31 million, with a cash balance of $12 million, giving it enough runway to invest in software-centric offerings. A sector-wide driver is the FCC’s recent spectrum repack, which is prompting agencies to upgrade legacy analog gear-an environment where BKTI’s dual-mode radios can capture share.
For a deeper quantitative view, the ValueRay platform offers a granular breakdown of BKTI’s valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 13.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.28 > 0.02 and ΔFCF/TA 16.35 > 1.0 |
| NWC/Revenue: 40.99% < 20% (prev 30.33%; Δ 10.66% < -1%) |
| CFO/TA 0.29 > 3% & CFO 19.7m > Net Income 13.0m |
| Net Debt (-20.6m) to EBITDA (15.8m): -1.31 < 3 |
| Current Ratio: 2.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.95m) vs 12m ago 5.34% < -2% |
| Gross Margin: 46.70% > 18% (prev 0.37%; Δ 4633 % > 0.5%) |
| Asset Turnover: 145.8% > 50% (prev 161.6%; Δ -15.79% > 0%) |
| Interest Coverage Ratio: 245.4 > 6 (EBITDA TTM 15.8m / Interest Expense TTM 57.0k) |
Altman Z'' 4.50
| A: 0.51 (Total Current Assets 51.7m - Total Current Liabilities 17.9m) / Total Assets 66.9m |
| B: -0.10 (Retained Earnings -6.54m / Total Assets 66.9m) |
| C: 0.25 (EBIT TTM 14.0m / Avg Total Assets 56.6m) |
| D: -0.16 (Book Value of Equity -4.09m / Total Liabilities 25.9m) |
| Altman-Z'' Score: 4.50 = AA |
Beneish M -3.29
| DSRI: 0.74 (Receivables 7.58m/9.35m, Revenue 82.6m/75.0m) |
| GMI: 0.78 (GM 46.70% / 36.55%) |
| AQI: 1.31 (AQ_t 0.15 / AQ_t-1 0.11) |
| SGI: 1.10 (Revenue 82.6m / 75.0m) |
| TATA: -0.10 (NI 13.0m - CFO 19.7m) / TA 66.9m) |
| Beneish M-Score: -3.29 (Cap -4..+1) = AA |
What is the price of BKTI shares?
Over the past week, the price has changed by +1.53%, over one month by -2.35%, over three months by -4.76% and over the past year by +132.30%.
Is BKTI a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BKTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 97 | 25.2% |
| Analysts Target Price | 97 | 25.2% |
| ValueRay Target Price | 105.2 | 35.8% |
BKTI Fundamental Data Overview February 04, 2026
P/S = 3.476
P/B = 7.0051
Revenue TTM = 82.6m USD
EBIT TTM = 14.0m USD
EBITDA TTM = 15.8m USD
Long Term Debt = 861.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 489.0k USD (from shortTermDebt, last quarter)
Debt = 861.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -20.6m USD (from netDebt column, last quarter)
Enterprise Value = 266.4m USD (287.0m + Debt 861.0k - CCE 21.5m)
Interest Coverage Ratio = 245.4 (Ebit TTM 14.0m / Interest Expense TTM 57.0k)
EV/FCF = 14.45x (Enterprise Value 266.4m / FCF TTM 18.4m)
FCF Yield = 6.92% (FCF TTM 18.4m / Enterprise Value 266.4m)
FCF Margin = 22.32% (FCF TTM 18.4m / Revenue TTM 82.6m)
Net Margin = 15.71% (Net Income TTM 13.0m / Revenue TTM 82.6m)
Gross Margin = 46.70% ((Revenue TTM 82.6m - Cost of Revenue TTM 44.0m) / Revenue TTM)
Gross Margin QoQ = 49.93% (prev 47.41%)
Tobins Q-Ratio = 3.98 (Enterprise Value 266.4m / Total Assets 66.9m)
Interest Expense / Debt = 4.53% (Interest Expense 39.0k / Debt 861.0k)
Taxrate = 29.71% (1.45m / 4.89m)
NOPAT = 9.83m (EBIT 14.0m * (1 - 29.71%))
Current Ratio = 2.89 (Total Current Assets 51.7m / Total Current Liabilities 17.9m)
Debt / Equity = 0.02 (Debt 861.0k / totalStockholderEquity, last quarter 41.0m)
Debt / EBITDA = -1.31 (Net Debt -20.6m / EBITDA 15.8m)
Debt / FCF = -1.12 (Net Debt -20.6m / FCF TTM 18.4m)
Total Stockholder Equity = 35.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 22.89% (Net Income 13.0m / Total Assets 66.9m)
RoE = 37.07% (Net Income TTM 13.0m / Total Stockholder Equity 35.0m)
RoCE = 39.02% (EBIT 14.0m / Capital Employed (Equity 35.0m + L.T.Debt 861.0k))
RoIC = 28.11% (NOPAT 9.83m / Invested Capital 35.0m)
WACC = 10.33% (E(287.0m)/V(287.8m) * Re(10.35%) + D(861.0k)/V(287.8m) * Rd(4.53%) * (1-Tc(0.30)))
Discount Rate = 10.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.25%
[DCF Debug] Terminal Value 60.51% ; FCFF base≈13.1m ; Y1≈8.62m ; Y5≈3.93m
Fair Price DCF = 20.29 (EV 55.1m - Net Debt -20.6m = Equity 75.7m / Shares 3.73m; r=10.33% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 82.69 | EPS CAGR: 36.19% | SUE: 0.54 | # QB: 0
Revenue Correlation: 69.94 | Revenue CAGR: 18.69% | SUE: 2.46 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.90 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=4.17 | Chg30d=+0.160 | Revisions Net=+1 | Growth EPS=+5.8% | Growth Revenue=+11.3%